Tag: Medtronic

To By-Pass or Not To By-Pass

In this educational supplement we focus on ischaemic stroke. We look at the results of the ASTER trial and experts weigh in on the...

Medtronic gets US FDA clearance for Riptide aspiration system

The Riptide aspiration system is intended for use in the revascularisation of patients with acute ischaemic stroke secondary to intracranial large vessel occlusive disease...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

FDA approves new clinician programmer for SynchroMed II intrathecal drug delivery...

The US Food and Drug Administration (FDA) has approved a new clinician programmer for use with the SynchroMed II Intrathecal Drug Delivery system (Medtronic),...

First patient enrolled in study to assess optimised spinal cord stimulation...

The first patient has been enrolled in the Vectors Post Market Clinical Study. The study will follow patients with chronic intractable pain who are...

Intellis platform receives CE mark for spinal cord and peripheral nerve...

Medtronic has received CE mark for the Intellis platform for both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) as an aid in...

FDA approves Intellis platform for chronic pain

The US Food and Drug Administration has approved the Intellis spinal cord stimulation platform (Medtronic) for the management of certain types of chronic intractable...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

SureTune3 earns CE mark for deep brain stimulation therapy

CE mark has been granted to the SureTune3 software (Medtronic) for deep brain stimulation (DBS). SureTune3 provides patient-specific visualisation of lead location and simulated...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

SureTune3 deep brain stimulation software receives Health Canada licence

Medtronic has received a Health Canada licence for SureTune3 software for deep brain stimulation (DBS). The latest innovations in the SureTune technology are designed...

Medtronic announces voluntary worldwide recall of its StrataMR adjustable valves and...

Medtronic has announced that on 22 February, 2017 it notified customers of a voluntary recall of all unused units of the StrataMR adjustable valves...

Better neck coverage with “bulged centre” of Barrel device in wide-necked...

A single-centre study reports that stent-assisted coiling with the Barrel stent (Medtronic) is a feasible, safe, and efficient method for embolisation of intracranial wide-necked...

FDA clears Reveal LINQ Insertable Cardiac Monitor with TruRhythm Detection

The US Food and Drug Administration (FDA) has given 510(k) clearance to Medtronic for its Reveal LINQ Insertable Cardiac Monitor (ICM) with TruRhythm Detection. A...

Medina embolisation device represents “a major step forward” in aneurysm treatment

According to a report of a single centre’s experience using the Medina embolisation device (Medtronic) for the treatment of unruptured aneurysms, the device “represents...

Introducing the new Solitaire™ Platinum Revascularization Device

The Solitaire™ Platinum Revascularization Device is the next generation into the Solitaire™ family which has an enhanced meaningful visibility that provides feedback during placement,...

FDA expands indication of Solitaire device

The US Food and Drug Administration (FDA) has cleared an expanded indication for the Solitaire stent retriever device (Medtronic). The FDA now allows the...

Medtronic announces voluntary recall of its Pipeline embolization device, Alligator retrieval...

Medtronic has announced that it has notified customers of a voluntary recall of certain lots of its Pipeline embolization device, Alligator retrieval device and...

Medtronic’s StealthStation cranial software receives FDA clearance as an aid for...

Medtronic has announced US Food and Drug Administration (FDA) clearance of StealthStation cranial software as an aid for deep brain stimulation (DBS) lead placement....

CE mark granted to Medtronic for SureTune2 deep brain stimulation therapy

Medtronic has received CE mark for SureTune2 software, which is designed to provide patient-specific visualisation to help physicians make decisions on how to program...

Medina Embolization Device and Pipeline Shield: LINNC Wrap Up Interviews

Find the latest updates from Prof Monika Killer and Dr Saleh Lamin following this year’s LINNC Congress in Paris. We consider our latest technologies,...

World Stroke Organisation and Medtronic to promote stroke awareness

  The World Stroke Organization has announced a global partnership with Medtronic to increase stroke awareness through several initiatives. The two organisations will work together with...

Medina Embolization Device

Medina™ is designed as an intra-saccular flow diverter, diverting flow away from the aneurysm sac and through the parent artery by forming a mesh scaffold...

Medtronic offer first complete portfolio of full-body MR conditional neurostimulation systems

The US Food and Drug Administration (FDA) has approved Medtronic’s Specify SureScan MRI surgical leads, which are indicated for use as part of Medtronic...

High-density stimulation restores efficacy in failed spinal cord stimulation therapy

By reprogramming existing spinal cord stimulation systems, investigators have been able to restore efficacy in patients who have failed spinal cord stimulation therapy, and...

Almost no learning curve with Barrel reconstruction device

The Barrel Vascular Reconstruction device (Medtronic) is one of the newest offerings for the treatment of intracranial bifurcation aneurysms. Since receiving the CE mark...

Medtronic and Samsung to collaborate on telehealth solutions for neuromodulation patients

Medtronic and Samsung Electronics America are to begin a broad-based strategic alliance aiming to speed up the development of digital health solutions for those...

Stent retriever technology named as a Top Medical Innovation by Cleveland...

Stent retriever technology has been named by the Cleveland Clinic as a top medical innovation. It was part of a list of the top...

Medtronic TYRX Neuro Absorbable Antibacterial Envelope now available for use with...

Medtronic plc has announced the first implants of the TYRX Absorbable Antibacterial Envelope with Medtronic deep brain stimulation (DBS) systems. The implants were conducted...

Medtronic acquires Lazarus Effect

Medtronic plc has announced that it has acquired Lazarus Effect, a Campbell, California, USA-based and privately-held medical device company focused on acute ischaemic stroke...

Medtronic launches Arc support catheter series in USA for treatment of...

Medtronic plc has announced the US launch of the Arc support catheter, the most navigable, 6F tapered support catheter available. Developed to improve delivery of...

Medtronic acquires Medina Medical

Medtronic plc has announced that it has acquired Medina Medical, a Menlo Park, California, USA-based and privately-held medical device company focused on commercialising state-of-the-art...

Radiation reduced with flow diversion for treatment of internal carotid artery...

According to new research, treatment of large and giant proximal internal carotid artery aneurysms using the Pipeline embolisation device (Covidien/Medtronic) requires less radiation, less...

Medtronic announces European approval of the first and only full-body MR...

The expanded approval for full-body MRI scans applies to all patients receiving a new system and to an estimated 13,000 people in Europe already receiving Medtronic DBS therapy.

Evidence builds for endovascular treatment of acute ischaemic stroke

With the publication of two more stroke trials, the evidence in favour of endovascular treatment in patients with acute ischaemic stroke has reached new heights. Data from SWIFT PRIME and REVASCAT add to that of three other trials-MR CLEAN, EXTEND-IA and ESCAPE-that have begun to change the face of ischaemic stroke treatment.

Next generation Medina coil system shows improvements in early human experience

In early use of the Medina coil system, researchers have found the device to be a next generation coil that combines the familiar procedural safety and technique associated with conventional coils, with improved circumferential aneurysm filling, which, they say, it is thought will lead to improved long-term outcomes.

Groundbreaking studies find that neurointerventional surgery reduces stroke mortality

Two new clinical trials on the treatment of stroke (ESCAPE and EXTEND IA) demonstrate that neurointerventional surgery significantly increases the number of patients who are able to live independently without major neurological disabilities.

FDA approves Pipeline Flex embolisation device

Designed to divert blood flow away from an aneurysm, the Pipeline Flex embolisation device (Medtronic) features a braided cylindrical mesh tube that is implanted across the base or neck of the aneurysm.